2020 American Transplant Congress
Combined Heart-Liver Transplantation: A Systematic Review of the Literature
*Purpose: Combined heart-liver transplant (CHLT) has been increasingly utilized as the treatment of choice for candidates with dual end-stage organ disease. We aimed to assess…2020 American Transplant Congress
Understanding Attitudes and Perceptions about Liver Disease and Living-Donor Liver Transplant- Results of a National Survey
*Purpose: There are more than 14,000 people on the national waiting list for a liver transplant. Approximately 25% will die before receiving a life-saving transplant…2020 American Transplant Congress
A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment
*Purpose: Hepatocellular carcinoma (HCC) constitutes 0.5% of childhood malignancies and exhibits poor prognosis. Complete tumor extirpation either by partial liver resection (LR) or liver transplantation…2020 American Transplant Congress
Improved Survival of Acute Liver Failure by “Off-the-Shelf” Bioartificial Liver Support System Using Immobilized Cryopreserved Hepatocyte Spheroids in Porcine Model
*Purpose: Acute liver failure (ALF) has a rapid and unpredictable onset with high mortality. The only current treatment is to transplant a donor organ but…2020 American Transplant Congress
The Impact of Occult Graft Fibrosis on Clinical Outcomes in Human Liver Transplant Recipients
1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan
*Purpose: Although liver transplantation (LT) has become a standard therapy for end-stage liver disease, early allograft dysfunction (EAD) and graft rejection remain serious unsolved problems.…2020 American Transplant Congress
Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells
1Hiroshima University, Hiroshima, Japan, 2University of Miami, Miami, FL
*Purpose: Development of an effective adjuvant therapy to prevent HCC recurrence after liver transplantation (LT) is an important medical requirement. Immunosuppressive regimens currently used after…2020 American Transplant Congress
Impact of Center Volume and MELD on Textbook Outcome Rates in Liver Transplantation
*Purpose: Textbook outcome (TO) is a composite quality metric used in liver transplantation (LT) and defined as patient and graft survival > 1 year, length…2020 American Transplant Congress
Factors Predicting Outcome after Living Donor Liver Transplantation in the Era of Intra-Operative Flow Measurements and Inflow Modulation
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: To identify pre/intra-operative factors which predict adverse outcome after living donor liver transplantation (LDLT).*Methods: All patients who underwent first LDLT at UPMC, Pittsburgh from…2020 American Transplant Congress
Ferroptotic Cell Death During Cold Storage is Essential in Liver Transplant Injury
*Purpose: It has been reported that activation of apoptosis signaling-regulating kinase 1 (ASK1)/p-p38 axis during tissue cold storage results in ferroptotic cell death. Ferroptosis is…2020 American Transplant Congress
Renoportal Vein Graft for Complete Portal Vein Thrombosis: A Reproducible Technique for a Challenging Problem
Baylor University Medical Center, Dallas, TX
*Purpose: Type-IV Yerdel portal vein thrombosis (PVT) was historically contraindicated in liver transplant due to lack of appropriate portal vein inflow. Renoportal vein graft (RPVG)…
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 180
- Next Page »